Granted Patent B2

US 12,156,751 · App. 17/190,238 · Granted Dec 3, 2024

Inventor: Robert Steven Newberry (New Hope, AL)

Assignee: Trilinear BioVentures, LLC

A61B5/7275A61B5/0002A61B5/0022A61B5/02416A61B5/14532A61B5/1455A61B5/14551A61B5/6817A61B5/743A61B5/6826A61B5/7225A61B2560/0223

Abstract

Claims (60)

1. A device, comprising:

at least one memory device that stores at least a first photoplethysmography (PPG) signal obtained from a first wavelength of light that is reflected from or transmitted through skin tissue of a user and a second PPG signal obtained at a second wavelength of light that is reflected from or transmitted through the skin tissue of the user;

at least one processing circuit configured to:

determine a first R value of the user using the first PPG signal and the second PPG signal, wherein the first R value is obtained using a first alternating current (AC) signal component in the first PPG signal and a second AC component in the second PPG signal;

compare the first R value of the user to a predetermined range of R values for a blood type of the user; and

determine an abnormal condition of the user in response to the comparison.

2. The device of claim 1 , wherein the processing circuit is configured to:

determine the first R value is outside the predetermined range of R values for the blood type of the user; and

determine the abnormal condition of the user when the first R value is outside the predetermined range of R values for the blood type of the user.

3. The device of claim 1 , wherein the processing circuit is configured to:

obtain the blood type of the user;

obtain the predetermined range of R values for the blood type of the user; and

determine whether the first R value of the user is within the predetermined range of R values for the blood type of the user.

4. The device of claim 1 , wherein the processing circuit is configured to:

determine a heart rate and a respiration rate of the user using at least the first PPG signal or the second PPG signal; and

determine the abnormal condition of the user using the heart rate of the user, the respiration rate of the user and the comparison of the first R value to the predetermined range of R values for the blood type of the user.

5. The device of claim 1 , wherein the processing circuit is configured to:

determine a change in color of blood of the user using at least the first PPG signal or the second PPG signal or a third PPG signal obtained at a third wavelength of light that is reflected from or transmitted through the skin tissue of the user; and

determine the abnormal condition of the user in response to at least one of: the change in the color of the blood of the user or the comparison of the first R value to the predetermined range of R values for the blood type of the user.

6. The device of claim 1 , wherein the memory is configured to store a plurality of normal ranges of R values, wherein each of the plurality of normal ranges of R values is associated with one of the plurality of blood types.

7. The device of claim 1 , wherein the processing circuit is configured to:

determine the abnormal condition of the user in response to the comparison, wherein the abnormal condition includes one or more of: an infection, anemia, genetic disease, sickle cell anemia, malaria, poison, tick-borne diseases, or blackwater fever.

8. The device of claim 1 , wherein the processing circuit is configured to determine the first R value of the user by:

determining a plurality of R values during a sample window of the first PPG signal and the second PPG signal, wherein the plurality of R values includes the first ratio R value; and

determining an average value or a mean value of the plurality of R values; and

determining the first R value of the user using the average value or the mean value of the plurality of R values.

9. The device of claim 1 , wherein the processing circuit is further configured to:

generate an indicator of the abnormal condition of the user.

10. A device, comprising:

at least one memory device that stores at least a first photoplethysmography (PPG) signal obtained from a first wavelength of light and a second PPG signal obtained from a second wavelength of light, each of the first PPG signal and the second PPG signal being reflected from or transmitted through skin tissue of a user;

at least one processing circuit configured to:

determine a change in a color of blood of the user using at least the first PPG signal and the second PPG signal, wherein the change in the color of blood is based on a spectral response as determined by the processing circuit based on at least the first PPG signal and the second PPG signal; and

determine an abnormal condition that affects red blood cells of the user in response to the change in the color of the blood of the user.

11. The device of claim 10 , wherein the processing circuit is configured to determine an abnormal condition that affects red blood cells of the user in response to the change in the color of the blood of the user by:

obtaining a predetermined range of colors of blood for a blood type of the user; and

determining the change in the color of the blood of the user is outside the predetermined range of colors of blood for the blood type of the user.

12. The device of claim 10 , wherein the processing circuit is further configured to:

determine a first R value of the user using the first PPG signal and the second PPG signal, wherein the first R value is obtained using a first alternating current (AC) signal component in the first PPG signal and a second AC component in the second PPG signal;

compare the first R value of the user to a predetermined range of R values for a blood type of the user; and

determine the abnormal condition of the user in response to the comparison of the first R value of the user to the predetermined range of R values for a blood type of the user.

13. The device of claim 12 , wherein the processing circuit is further configured to:

determine the first R value is outside the predetermined range of R values for the blood type of the user; and

determine the abnormal condition of the user in response to the first R value being outside the predetermined range of R values for the known blood type of the user.

14. The device of claim 13 , wherein the processing circuit is configured to:

determine a heart rate and a respiration rate of the user using at least the first PPG signal or the second PPG signal; and

determine the abnormal condition of the user using at least one of: the first R value being outside the predetermined range of R values for the known blood type of the user or the heart rate of the user or the respiration rate of the user.

15. A device, comprising:

a memory that stores at least a first photoplethysmography (PPG) signal at a first wavelength and a second PPG signal at a second wavelength obtained from a user;

a processing circuit configured to:

determine a plurality of first R values over a sample window using the first PPG signal and the second PPG signal;

determine a first R value of the user using the plurality of first R values, wherein the first R value is determined using at least one of: an average of the plurality of first R values, a mean of the plurality of first R values, and an integration of the plurality of first R values; and

determine the first R value is outside a normal range of R values for the blood type of the user; and

generate an alert of an abnormal result in response to the first R value being outside the normal range of R values for the known blood type of the user.

16. The device of claim 15 , wherein the processing circuit is further configured to:

determine an abnormal condition of the user in response to the first R value being outside the normal range of R values for the known blood type of the user; and

generate an alert of the abnormal condition.

17. The device of claim 16 , wherein the processing circuit is further configured to:

determine a change in the color of the blood of the user using at least a third PPG signal at a third wavelength; and

determine the abnormal condition that affects red blood cells of the user in response to at least one of: the change in the color of the blood of the user or the first R value being outside the normal range of R values for the known blood type of the user.

18. The device of claim 17 , wherein the abnormal condition causes hemolysis of at least 0.5% of the red blood cells of the blood of the user.

Assignments (3)

Continuity (16)